Red flags / Officer or director exit
Teva's Chief Medical Officer Eric Hughes resigns effective immediately
Teva disclosed that Dr. Eric Hughes, Executive Vice President, Global R&D and Chief Medical Officer, notified the company on November 17, 2026 of his intention to resign and will step down immediately, staying on to assist with a transition over the next few months. The filing names no successor and gives no reason for the departure. Sudden exits of senior R&D leaders can raise questions about the continuity of the company's pipeline and clinical programs.
“Dr. Hughes will step down immediately from his role and will continue to assist with a smooth transition over the next few months.”
What the stock did
From the last close before the filing was public. Market cap now: $45.8B.
1 day
-8.7%
SPY -2.0%
5 days
Not yet
20 days
Not yet
8-K Item 5.02: a CEO, CFO or director left suddenly or over a disagreement. Flags are a screen for filings worth reading, not advice. Read the filing before acting on it.
Other flags on TEVA
| Filed | Stock | Flag | What the filing says | Mkt cap | 5 days | 20 days |
|---|---|---|---|---|---|---|
| Nov 12, 4:11 PM ET | TEVA Teva Pharmaceutical Industries Limited | Insider selling cluster ElevatedForm 4 | 3 officers and directors sold $3.8M of Teva Pharmaceutical Industries Limited stock in 10 days | $45.8B | -11.7% | - |